BRIEF published on 11/07/2024 at 07:05, 14 days 6 hours ago Swiss Re renforce ses réserves de responsabilité civile aux États-Unis dans le cadre d'un examen complet Objectifs Financiers Swiss Re Résultats 2024 Réserves De Passif Des États-Unis Assurance P&C
PRESS RELEASE published on 11/07/2024 at 07:00, 14 days 6 hours ago Swiss Re strengthens US liability reserves, following a comprehensive reserve review Swiss Re strengthens US liability reserves by USD 2.4 billion in Q3 2024, positioning overall reserves at the higher end of the best-estimate range Financial Results Swiss Re US Liability Reserves P&C Re Reserve Review
BRIEF published on 11/05/2024 at 09:05, 16 days 4 hours ago Swiss Re cède l'activité IARD européenne d'iptiQ à Allianz Direct Désinvestissement De Swiss Re Vente IptiQ Acquisition Directe D'Allianz Marché Européen De L'assurance IARD Assurance B2B2C
BRIEF published on 11/05/2024 at 09:05, 16 days 4 hours ago Swiss Re to Divest iptiQ's European P&C Business to Allianz Direct Swiss Re Divestment IptiQ Sale Allianz Direct Acquisition European P&C Market B2B2C Insurance
PRESS RELEASE published on 11/05/2024 at 09:00, 16 days 4 hours ago Swiss Re agrees to sell iptiQ's European P&C business to Allianz Direct Swiss Re to sell iptiQ's European P&C business to Allianz Direct in strategic move. Transaction includes various European markets and is expected to close in Q2/Q3 2025, pending regulatory approvals Insurance Swiss Re Mergers & Acquisitions European Markets Allianz Direct
BRIEF published on 09/16/2024 at 10:05, 2 months 5 days ago Le Covid-19 pourrait entraîner la plus longue période de surmortalité en temps de paix, selon un nouveau rapport de Swiss Re Impact Du COVID-19 Surmortalité Perturbation Des Soins De Santé Risque D'assurance Progrès Médicaux
BRIEF published on 09/16/2024 at 10:05, 2 months 5 days ago Covid-19 May Lead to Longest Period of Peacetime Excess Mortality, Says New Swiss Re Report COVID-19 Impact Excess Mortality Healthcare Disruption Insurance Risk Medical Advancements
PRESS RELEASE published on 09/16/2024 at 10:00, 2 months 5 days ago Covid-19 may lead to longest period of peacetime excess mortality, says new Swiss Re report Swiss Re report warns of potential long-lasting peacetime excess mortality due to COVID-19 impact. Excess mortality rates may remain up to 3% higher in the US and 2.5% in the UK by 2033 COVID-19 Healthcare Research Swiss Re Excess Mortality
BRIEF published on 09/09/2024 at 07:05, 2 months 12 days ago Swiss Re constate une demande croissante de réassurance dans un environnement volatil Réassurance Catastrophes Naturelles Instabilité Économique Assurance Cybernétique Environnement Contentieux
BRIEF published on 09/09/2024 at 07:05, 2 months 12 days ago Swiss Re sees increasing demand for reinsurance in volatile environment Reinsurance Cyber Insurance Natural Catastrophes Economic Instability Litigation Environment
Published on 11/21/2024 at 13:00, 19 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 19 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 19 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 19 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 19 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 43 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 3 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 49 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 21 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 11 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 59 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
